Proscia

Ibex Medical Analytics is the pioneer in AI-powered cancer diagnostics in pathology. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision is transforming cancer diagnostics with AI and improving patient care. Pathologists are challenged to provide accurate and timely analysis as the number of tests increases every year. Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that help detect cancer as accurately as a human pathologist. Galen Platform uses algorithms to analyze images, detect and grade cancer in biopsies and point to other findings with high clinical importance, helping pathologists reduce diagnostic error rates and enable a more efficient workflow. Ibex’s Galen™ Prostate and Galen™ Breast are the first-ever AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases.

Affordable Cloud-based LIS. Perfect for startup labs! Subscriptions start at $250/month including 3 analyzer interfaces unlimited users. CLIA-compliance suite makes it easy to comply with regulatory requirements. Easy-to-use application can be installed in a day and web-training available. LIS is easily configured to meet your exact analyzer and workflow requirements. HIPAA-compliant Phone app supports patient registration, test order and results notification. We have more than 300 deployments with clients specializing in: Fertility, Genetic testing, molecular testing, Pathology, Toxicology and virtually all other specialties. We have interfaced over 250 different analyzers including interfaces to the leading analyzers in the fields of molecular biology and genetic testing.